Table 1 Patient characteristics

N (%)

286 (29.5)

685 (70.5)

Age (years)

56.5 ± 13.3

59.3 ± 11.7

0.001

Male (%)

71.7

78.4

0.016

BMI (Kg/m²)

24.6 ± 3.6

25.8 ± 4.1

<0.001

SBP (mm Hg)

137.3 ± 20.4

137.4 ± 21.5

0.975

DBP (mm Hg)

79.3 ± 13.6

79.4 ± 14.3

0.926

AHI

1.7 ± 1.4

22.0 ± 16.7

0.001

IVS (mm)

10.7 ± 1.8

11.4 ± 2.3

<0.001

LVPW (mm)

10.2 ± 1.8

10.5 ± 1.8

0.007

HbA1c (%)

6.1 ± 1.1

6.3 ± 1.2

0.029

Creatinine (μmol/L)

91.6 ± 48.0

99.0 ± 65.9

0.098

BUN (mmol/L)

5.5 ± 3.2

5.8 ± 2.8

0.162

FPG (mmol/L)

6.2 ± 2.6

6.5 ± 3.0

0.130

Triglyceride (mmol/L)

1.9 ± 0.3

1.8 ± 0.1

0.582

Total cholesterol (mmol/L)

4.5 ± 1.3

4.5 ± 1.2

0.643

LDL-C (mmol/L)

2.7 ± 1.0

2.7 ± 1.0

0.939

HDL-C (mmol/L)

1.0 ± 0.3

1.0 ± 0.2

0.961

Proteinuria (%)

17.1

20.4

0.183

Diabetes mellitus (%)

19.6

24.4

0.061

Dyslipidemia (%)

10.5

14.6

0.052

Aortic dissection (%)

20.3

19.9

0.472

Aneurysm (%)

4.5

5.4

0.354

CHD (%)

37.4

41.9

0.110

Cerebrovascular disease (%)

6.6

9.9

0.063

Heart failure (%)

19.2

21.9

0.200

Atrial fibrillation (%)

8.4

9.1

0.424

HCM (%)

1.7

3.4

0.121

Anti-platelet (%)

49.0

54.3

0.073

Statins (%)

59.1

66.9

0.013

ACEI (%)

22.0

22.0

0.534

ARB (%)

49.7

46.0

0.165

Beta-blocker (%)

59.4

66.4

0.023

Alpha-blocker (%)

6.6

6.4

0.500

CCB (%)

55.2

57.1

0.324

Diuretic (%)

16.1

18.7

0.192

Warfarin (%)

6.6

7.2

0.448